NBGI Ventures’ first fund, raised in 2001, has been invested in eight early stage technology companies primarily based in Europe and has achieved its first partial exit returning a gross IRR of more than 100%.
The new fund will adopt the same investment strategy focusing on early stage medical technology businesses based in Europe, investing between €1m and €9m per company.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: